{"schema_version":"secwatch.filing_event.v1","accession":"0001809519-24-000133","form_type":"8-K","ticker":"GDRX","cik":"0001809519","company_name":"GoodRx Holdings, Inc.","filed_at":"2024-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.603600+00:00","generated_at":"2026-05-31T22:12:48.717986+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"GoodRx adds former Genentech CEO Ian Clark to board, creates Innovation Committee","bullets":["Ian T. Clark elected Class III director effective July 8, 2024; fills vacancy from Stephen LeSieur's March resignation.","Clark chairs newly created Innovation Committee; also joins Nominating and Corporate Governance Committee.","Granted initial RSU award worth $420,000 and pro-rated annual award of $209,836 under director compensation plan.","Board combined Audit and Compliance committees into a single Audit and Risk Committee.","Clark brings 35+ years pharma/healthcare experience; board deems him independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001809519-24-000133","json":"https://secwatch.observer/filing/0001809519-24-000133.json","markdown":"https://secwatch.observer/filing/0001809519-24-000133.md","text":"https://secwatch.observer/filing/0001809519-24-000133.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000133/0001809519-24-000133-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000133/gdrx-20240708.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:12:48.717986+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be2f4b1bc6","claim":"Ian T. Clark was elected as Class III Director at GoodRx Holdings, Inc..","evidence_excerpt":"On July 8, 2024, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, elected Ian T. Clark as a Class III director, effective immediately, to fill the vacancy on the Board created by the resignation of Stephen LeSieur.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951924000133/0001809519-24-000133-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}